Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.
Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.
Atridox™ combines the antibiotic doxycycline with a unique gel that the dentist applies to periodontal pockets to fight the bacteria that cause this chronic infection in adults. Atridox™ continuously releases the antibiotic over seven days to safely fight the periodontal infection.
For more details, contact Block Drug Corporation at (800) 365-6500.
Office managers are the heart of every practice, valued for their compassion, dedication, and exceptional skill. This year’s Spa Day giveaway highlighted their impact—from problem...
Just as no treatment plan is exactly the same, neither are any two patients’ financial situations. Financial barriers can stand in the way of a patient receiving the care they...
One practice, multiple locations. It sounds pretty simple, but we know it requires an intentional, multilayered strategy to be successful. Discover how implementing cloud-based...
Cost limitations can be a big barrier to patients’ acceptance of dental care treatments. Click to learn more about Patterson CarePay+, a single, comprehensive financing option...
